Intervention
venlafaxine
ClinicalTrials.gov intervention label
Clinical trials
9 shownNeurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression DisorderNCT02346682 · 2015-02-01
UNKNOWNIncomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineNCT02263248 · 2014-12-01
COMPLETEDComparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionNCT01824433 · 2013-03-07
COMPLETEDTamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or SertralineNCT00667121 · 2011-03-16
COMPLETEDRandomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of DepressionNCT00627887 · 2008-01-01
COMPLETEDA Study Of New Medicine (GSK 372475) For The Treatment Of DepressionNCT00448058 · 2007-04-01
COMPLETEDStudy of Antidepressants in Parkinson's DiseaseNCT00086190 · 2005-06-01
COMPLETEDVenlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast CancerNCT00084669 · 2004-05-01
COMPLETEDVenlafaxine for Hot Flashes After Breast CancerNCT00198250 · 2000-05-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED8
UNKNOWN1
Phase mix
PHASE23
PHASE43
NA1
PHASE11
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.